OnSkin App Helps Consumers Assess Household Care Ingredients

Cosmetic scanner OnSkin says it is enabling consumers to make more informed decisions about the household cleaning products they use every day.

“Compared to cosmetics, household cleaning products are subject to less consistent regulatory disclosure requirements, making them more difficult to interpret,” explained Julia Kuprina, OnSkin’s product director. “Ingredients on labels may appear under generic group or even functional names, while individual chemical names may be listed irregularly and lack reliable scientific data.”

This, she added, significantly limits transparency regarding substances that were exposed to the skin or may be accidentally inhaled during use.

“Since our goal is to reduce uncertainty for consumers and support healthier choices for themselves, their families, and their home environments, we treat lack of transparency as a risk signal in itself,” she noted. “When composition cannot be verified, safety cannot be confidently established.”

Unique Safety Scoring

The new functionality applies a comprehensive safety scoring methodology developed by OnSkin’s team of medical and scientific experts based on verified data from authoritative industrial, toxicological, and medical sources, per officials.

Officials say each component included in a product’s composition for performance is thoroughly evaluated against five health risk factors: respiratory irritation, allergic reactions and skin or eye irritation, endocrine disruption and reproductive toxicity, carcinogenicity, and usage restrictions. These assessments produce an overall safety score on a 100-point scale, ranging from excellent to bad, indicating the potential adverse effects a given product may have on human health.

Within household chemical evaluation, OnSkin introduces an ingredient transparency indicator. A “good” rating signals all ingredients can be evaluated; “partial” reflects cases where more than 30% of ingredients may have an unknown impact; and “poor” indicates that over 70% of the formulation can’t be fully assessed.